-
1
-
-
2142746439
-
FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis
-
Shimada T, Hasegawa H, Yamazaki Y et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 2004; 19: 429-435
-
(2004)
J Bone Miner Res
, vol.19
, pp. 429-435
-
-
Shimada, T.1
Hasegawa, H.2
Yamazaki, Y.3
-
2
-
-
59749105862
-
Relationship between plasma FGF-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis
-
Wesseling-Perry K, Pereira RC, Wang H et al. Relationship between plasma FGF-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis. J Clin Endocrinol Metab 2009; 94: 511-517
-
(2009)
J Clin Endocrinol Metab
, vol.94
, pp. 511-517
-
-
Wesseling-Perry, K.1
Pereira, R.C.2
Wang, H.3
-
3
-
-
84885226527
-
Plasma FGF23 levels increase rapidly after acute kidney injury
-
Christov M, Waikar SS, Pereira RC et al. Plasma FGF23 levels increase rapidly after acute kidney injury. Kidney Int 2013; 84: 639-641
-
(2013)
Kidney Int
, vol.84
, pp. 639-641
-
-
Christov, M.1
Waikar, S.S.2
Pereira, R.C.3
-
4
-
-
33747719260
-
Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men
-
Antoniucci DM, Yamashita T, Portale AA. Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. J Clin Endocrinol Metab 2006; 91: 3144-3149
-
(2006)
J Clin Endocrinol Metab
, vol.91
, pp. 3144-3149
-
-
Antoniucci, D.M.1
Yamashita, T.2
Portale, A.A.3
-
5
-
-
84872242826
-
Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease
-
Wan M, Smith C, Shah V et al. Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease. Nephrol Dial Transplant 2013; 28: 153-161
-
(2013)
Nephrol Dial Transplant
, vol.28
, pp. 153-161
-
-
Wan, M.1
Smith, C.2
Shah, V.3
-
6
-
-
49249104701
-
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
-
Gutierrez OM, Mannstadt M, Isakova T et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 2008; 359: 584-592
-
(2008)
N Engl J Med
, vol.359
, pp. 584-592
-
-
Gutierrez, O.M.1
Mannstadt, M.2
Isakova, T.3
-
7
-
-
79958724181
-
Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease
-
Isakova T, Xie H, Yang W et al. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA 2011; 305: 2432-2439
-
(2011)
JAMA
, vol.305
, pp. 2432-2439
-
-
Isakova, T.1
Xie, H.2
Yang, W.3
-
8
-
-
79955603792
-
Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality
-
Wolf M, Molnar MZ, Amaral AP et al. Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality. J Am Soc Nephrol 2011; 22: 956-966
-
(2011)
J Am Soc Nephrol
, vol.22
, pp. 956-966
-
-
Wolf, M.1
Molnar, M.Z.2
Amaral, A.P.3
-
9
-
-
0344945402
-
Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers
-
Larsson T, Nisbeth U, Ljunggren O et al. Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int 2003; 64: 2272-2279
-
(2003)
Kidney Int
, vol.64
, pp. 2272-2279
-
-
Larsson, T.1
Nisbeth, U.2
Ljunggren, O.3
-
10
-
-
80555148939
-
FGF23 induces left ventricular hypertrophy
-
Faul C, Amaral AP, Oskouei B et al. FGF23 induces left ventricular hypertrophy. J Clin Invest 2011; 121: 4393-4408
-
(2011)
J Clin Invest
, vol.121
, pp. 4393-4408
-
-
Faul, C.1
Amaral, A.P.2
Oskouei, B.3
-
11
-
-
9344242932
-
Coronary artery calcification in patients with CRF not undergoing dialysis
-
Russo D, Palmiero G, De Blasio AP et al. Coronary artery calcification in patients with CRF not undergoing dialysis. Am J Kidney Dis 2004; 44: 1024-1030
-
(2004)
Am J Kidney Dis
, vol.44
, pp. 1024-1030
-
-
Russo, D.1
Palmiero, G.2
De Blasio, A.P.3
-
12
-
-
3543139492
-
Mineral metabolism, mortality, and morbidity in maintenance hemodialysis
-
Block GA, Klassen PS, Lazarus JM et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004; 15: 2208-2218
-
(2004)
J Am Soc Nephrol
, vol.15
, pp. 2208-2218
-
-
Block, G.A.1
Klassen, P.S.2
Lazarus, J.M.3
-
13
-
-
0037337818
-
Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels
-
Moe SM, Duan D, Doehle BP et al. Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels. Kidney Int 2003; 63: 1003-1011
-
(2003)
Kidney Int
, vol.63
, pp. 1003-1011
-
-
Moe, S.M.1
Duan, D.2
Doehle, B.P.3
-
14
-
-
34248512085
-
Mineralized tissue cells are a principal source of FGF23
-
Yoshiko Y, Wang H, Minamizaki T et al. Mineralized tissue cells are a principal source of FGF23. Bone 2007; 40: 1565-1573
-
(2007)
Bone
, vol.40
, pp. 1565-1573
-
-
Yoshiko, Y.1
Wang, H.2
Minamizaki, T.3
-
16
-
-
77951726222
-
Fibroblast growth factor (FGF)-23 and fetuin-A in calcified carotid atheroma
-
Voigt M, Fischer DC, Rimpau M et al. Fibroblast growth factor (FGF)-23 and fetuin-A in calcified carotid atheroma. Histopathology 2010; 56: 775-788
-
(2010)
Histopathology
, vol.56
, pp. 775-788
-
-
Voigt, M.1
Fischer, D.C.2
Rimpau, M.3
-
17
-
-
70350223807
-
Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease
-
Pereira RC, Jüppner H, Azucena-Serrano CE et al. Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease. Bone 2009; 45: 1161-1168
-
(2009)
Bone
, vol.45
, pp. 1161-1168
-
-
Pereira, R.C.1
Jüppner, H.2
Azucena-Serrano, C.E.3
-
18
-
-
0035710746
-
Analysis of relative gene expression data using real-Time quantitative PCR and the 2(-Delta Delta C(T)) Method
-
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-Time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408
-
(2001)
Methods
, vol.25
, pp. 402-408
-
-
Livak, K.J.1
Schmittgen, T.D.2
-
19
-
-
79957870135
-
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
-
Isakova T, Wahl P, Vargas GS et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 2011; 79: 1370-1380
-
(2011)
Kidney Int
, vol.79
, pp. 1370-1380
-
-
Isakova, T.1
Wahl, P.2
Vargas, G.S.3
-
20
-
-
84857069906
-
Early skeletal and biochemical alterations in pediatric chronic kidney disease
-
Wesseling-Perry K, Pereira RC, Tseng CH et al. Early skeletal and biochemical alterations in pediatric chronic kidney disease. Clin J Am Soc Nephrol 2012; 7: 146-152
-
(2012)
Clin J Am Soc Nephrol
, vol.7
, pp. 146-152
-
-
Wesseling-Perry, K.1
Pereira, R.C.2
Tseng, C.H.3
-
21
-
-
77957606585
-
Phosphorus and coronary calcification in predialysis patients
-
Russo D, Battaglia Y, Buonanno E. Phosphorus and coronary calcification in predialysis patients. Kidney Int 2010; 78: 818
-
(2010)
Kidney Int
, vol.78
, pp. 818
-
-
Russo, D.1
Battaglia, Y.2
Buonanno, E.3
-
22
-
-
14544308827
-
Mechanisms of vascular calcification in renal disease
-
Shanahan CM. Mechanisms of vascular calcification in renal disease. Clin Nephrol 2005; 63: 146-157
-
(2005)
Clin Nephrol
, vol.63
, pp. 146-157
-
-
Shanahan, C.M.1
-
23
-
-
84882238083
-
Fibroblast growth factor 23 is not associated with and does not induce arterial calcification
-
Scialla JJ, Lau WL, Reilly MP et al. Fibroblast growth factor 23 is not associated with and does not induce arterial calcification. Kidney Int 2013; 83: 1159-1168
-
(2013)
Kidney Int
, vol.83
, pp. 1159-1168
-
-
Scialla, J.J.1
Lau, W.L.2
Reilly, M.P.3
-
24
-
-
44449118964
-
Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro
-
Wang H, Yoshiko Y, Yamamoto R et al. Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro. J Bone Miner Res 2008; 23: 939-948
-
(2008)
J Bone Miner Res
, vol.23
, pp. 939-948
-
-
Wang, H.1
Yoshiko, Y.2
Yamamoto, R.3
-
26
-
-
78651408919
-
Klotho deficiency causes vascular calcification in chronic kidney disease
-
Hu MC, Shi M, Zhang J et al. Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol 2011; 22: 124-136
-
(2011)
J Am Soc Nephrol
, vol.22
, pp. 124-136
-
-
Hu, M.C.1
Shi, M.2
Zhang, J.3
-
27
-
-
84860778116
-
Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to FGF-23
-
Lim K, Lu TS, Molostvov G et al. Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to FGF-23. Circulation 2012; 125: 2243-2255
-
(2012)
Circulation
, vol.125
, pp. 2243-2255
-
-
Lim, K.1
Lu, T.S.2
Molostvov, G.3
-
28
-
-
80052303008
-
Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo
-
Rhee Y, Bivi N, Farrow E et al. Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo. Bone 2011; 49: 636-643
-
(2011)
Bone
, vol.49
, pp. 636-643
-
-
Rhee, Y.1
Bivi, N.2
Farrow, E.3
|